Skip to main content
Fig. 6 | Cancer Imaging

Fig. 6

From: Multi-center evaluation of machine learning-based radiomic model in predicting disease free survival and adjuvant chemotherapy benefit in stage II colorectal cancer patients

Fig. 6

The prognosis value for predicting adjuvant chemotherapy (ACT) benefit in the training set using the cutoff value of radiomics score (optimal cutoff value of 0.1215). A Survival analysis of ACT benefit in the training set. B Survival analysis of ACT benefit in patients with low radiomics score. C Survival analysis of ACT benefit in patients with high radiomics score. Two-sided P values for comparison of DFS were computed using the log-rank test

Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us